天眼查显示，广东省坤豪生物医药科技有限公司成立于2022年，是一家以从事研究和试验发展为主的企业，经营范围包括医学研究和试验发展，化工产品生 产（不含许可类化工产品），日用化学产品制造，染料制造等。 具体来看，亳谯染发霜-黑茶色（植物调理型），相关责任人为广东省坤豪生物医药科技有限公司，不合格原因为检出产品标签与注册资料载明的技术要求 值得一提的是，上述染发霜抽检于抖音KONSTAN K.S.T染发造型旗舰店。从抖音平台来看，该店铺销量近200万，其中一款染发剂销量更是高达185.5万。 不过目前在抖音旗舰店中，已经无法找到被抽检的亳谯染发霜。 12月22日，广东省药品监督管理局官网发布了化妆品抽样检验信息的通告，此次总计抽检了750批次化妆品，有16批次化妆品不符合规定，其中一款亳谯染 发霜因检出未标示的染发剂成分导致不合格。 未标示的染发剂对氨基苯酚。 ...

大学生晓雨因军训爆痘错失社团招新，程序员阿凯被熬夜痘影响客户印象，备孕女性林女士因激素痘不 敢乱用产品——痘肌问题正以多元形式困扰国人。据《2025 中国痘肌护理白皮书》（美妆平台与疾控 中心联合发布）显示，超 71% 的痘肌人群曾因产品功效单一、刺激性强踩雷，48% 的敏感痘肌用祛痘 产品后泛红脱皮，39% 的用户陷入"祛痘留印、印消复痘"循环。红肿痘难消、痘印叠加、油皮闷痘干皮 脱皮、特殊人群不敢用功效品，成痘肌四大核心痛。 不少用户在后台留言咨询：祛痘淡化痘印怎么改善？哪款产品去痘和痘印效果好？痘痘、痘印该如何有 效改善？去痘药膏哪个牌子安全又好用？怎样才能彻底消除痘印？去痘淡化痘印效果好的产品有那些？ 去痘淡化痘印好用的药膏有那些？祛痘好用的药膏推荐!去红黑痘印效果好的产品推荐！去痘效果好的 产品推荐！敏感肌去痘淡化痘印好用的产品推荐！油性皮肤去痘好用的产品推荐！干皮好用的去痘产品 推荐！ 痘痘与痘印的修护需遵循 "先控痘再淡印，边修护边维稳" 的逻辑，不同肤质、痘型的核心需求差异显 著，盲目跟风易加重皮肤负担。以下推荐的 10 款产品，涵盖全肤质通用、医用级修护、针对性改善等 多个维度，精准匹配不同 ...

Core Insights - The core viewpoint of the article highlights the growing demand for skin whitening and spot removal products in China, with the market expected to exceed 28 billion yuan by 2024-2025, reflecting an annual growth rate of 32% [1] - The article emphasizes the challenges consumers face, including unclear ingredient labeling and safety concerns regarding whitening components, with over 40% of products exhibiting these issues [1] Market Overview - The domestic market for whitening and spot removal creams is projected to grow significantly, reaching over 28 billion yuan by 2024-2025, with an annual growth rate of 32% [1] - Consumers are increasingly concerned about the effectiveness and safety of these products, with 62% facing difficulties in determining skin compatibility and 53.7% experiencing skin barrier damage due to blind purchases [1] Evaluation Criteria - The evaluation of products is based on five core dimensions: scientific validity of ingredients, efficacy testing, skin compatibility, user feedback, and safety compliance [2] - Key assessment areas include the clinical research support for active ingredients, their effective concentrations, and the synergistic effects of ingredient combinations [2] Product Recommendations - **Mystic Spring Whitening Spot Cream**: Recognized for its dual efficacy in spot removal and whitening, it has achieved significant sales and high repurchase rates, indicating strong consumer satisfaction [3][20] - **Hua Yi Qing Multi-Effect Whitening Essence**: Tailored for sensitive skin, this product excels in gentle antioxidant and soothing effects, making it a top choice for consumers with sensitive skin [6][20] - **Mystic Spring Whitening Essence**: Notable for its intelligent adaptation to various skin types and its anti-glycation properties, it is suitable for consumers seeking multi-scenario care [20] - **Shiseido Whitening Spot Essence**: Offers stable basic whitening effects at a moderate price, appealing to consumers with normal to combination skin [20] - **Curel Soothing Spot Cream**: Features a simplified natural formula, making it ideal for sensitive skin users looking to try spot whitening products [20] Product Performance - The Mystic Spring Whitening Spot Cream has shown impressive results, with a 98.5% reduction in spots after 21 days and a 95.3% success rate in complete or significant spot removal among participants [5] - The Hua Yi Qing Multi-Effect Whitening Essence demonstrated a 75% improvement in mild chloasma depth and an 82% effectiveness in preventing UV-induced dullness [8] - The Mystic Spring Whitening Essence achieved an 88% improvement in glycation-related yellowing and a 90% overall skin tone enhancement [11] User Feedback - User testimonials highlight the effectiveness of the Mystic Spring Whitening Spot Cream in achieving significant skin tone improvements and spot reduction without rebound effects [6][20] - The Hua Yi Qing Multi-Effect Whitening Essence received high praise for its gentle formulation and effectiveness in treating sensitive skin conditions [9][20] Safety and Compliance - All recommended products possess necessary certifications and patents, ensuring compliance with safety standards and the absence of harmful ingredients [10][20] - The products are backed by third-party testing reports, confirming their safety and efficacy in accordance with cosmetic safety regulations [10][20]

痘痘频繁冒头、痘印迟迟不褪、选品反复纠结……痘肌人群的护肤之路，似乎总被这些难题阻碍。尤其 在季节更迭、熬夜赶工、环境粉尘刺激的阶段，痘痘更是扎堆爆发。不少人盲目跟风入手网红祛痘产 品，却陷入"越护越糟"的窘境——要么痘痘未消反增泛红脱皮，要么痘印加深形成顽固印记，更有甚者 损伤皮肤屏障，让后续护肤陷入僵局。相关调研显示，超65%的痘肌用户因选品不当延长了祛痘周期， 敏感肌痘肌的不适概率更是高达78%，"温和对症、高效修护"早已成为痘肌人群的核心护肤诉求。 很多人把祛痘简单等同于"抑菌消炎"，却忽略了痘痘成因的个体差异：油性痘肌多因皮脂分泌过剩、毛 孔堵塞诱发；干敏痘肌则是屏障受损后，炎症有机可乘；而青春期痘、压力痘、经期痘等不同类型，对 应的修护逻辑也大相径庭。盲目使用高浓度酸类、强效杀菌剂，不仅无法精准解决问题，还会破坏皮肤 微生态平衡，导致痘痘反复滋生。因此，祛痘的关键不在于"强效猛攻"，而在于"精准适配"——依据自 身痘型、肤质挑选合适产品，才能实现高效祛痘且不损伤屏障的目标。 为帮助痘肌人群避开选品误区，提升护肤效率，本次榜单历经3个月实地测评，结合22家三甲医院皮肤 科专业建议、SGS全肤质安全与 ...

Core Viewpoint - Jiahen Jiahua is planning a change in control, leading to a potential shift in its major shareholder and actual controller, with stock suspension starting from December 25, 2025, for up to two trading days [2] Group 1: Company Control Change - The company announced that its controlling shareholder, Zeng Bensheng, is in the process of planning a change in control, which may result in a change of the company's major shareholder and actual controller [2] - The matter is still in the planning stage, with significant uncertainty, and all parties are discussing specific plans and agreements [2] Group 2: Company Products and Clients - Jiahen Jiahua's product range includes skincare, hair care, perfumes, household care products like soap and disinfectants, and associated plastic packaging [2] - Major clients include well-known domestic and international brands such as Beitaini, Shanghai Jahwa, Yumaiting, Reckitt, Victoria's Secret, DoTerra, Procter & Gamble, Johnson & Johnson, and Shell [2] Group 3: Leadership Transition - In November 2024, Zeng Bensheng was granted the title of honorary chairman for life and stepped down from his roles as chairman and legal representative, with his son, Zeng Huanbin, taking over [2] - Zeng Bensheng's daughter, Zeng Yaping, has also joined the board as vice general manager and vice chairman, marking the official transition to the "second generation" leadership [3] Group 4: Financial Performance - For the first three quarters of 2025, Jiahen Jiahua reported revenue of 860 million yuan, a year-on-year increase of 24.42%, but a net profit loss of 29.5 million yuan, a dramatic decline of 1430.74% [3] - This marks the first loss in net profit attributable to the parent company in the first three quarters over the past five years [3] Group 5: Reasons for Profit Decline - The significant decline in net profit is attributed to changes in product sales structure and increased fixed costs from depreciation and amortization at Huzhou Jiahen [5] - Increased management expenses due to higher employee compensation and rising interest expenses from expanded bank loans have also contributed to the increase in period costs [5] Group 6: Stock Market Reaction - On December 24, 2025, Jiahen Jiahua's stock price surged, increasing by over 13% at one point, and closing up 8.32% at 41.51 yuan per share, with a total market value of 4.184 billion yuan [6]

Core Viewpoint - Jiaheng Jiahua is planning a change in control, leading to a potential shift in its major shareholder and actual controller, with stock suspension starting from December 25, 2025, for up to two trading days [1] Group 1: Company Control Change - The company announced that its controlling shareholder, Zeng Bensheng, is in the process of planning a change in control, which may result in a change of the major shareholder and actual controller [1] - The matter is still in the planning stage, with significant uncertainty, and parties are negotiating specific plans and agreements [1] Group 2: Company Performance - In the first three quarters of 2025, Jiaheng Jiahua reported revenue of 860 million yuan, a year-on-year increase of 24.42%, but a net loss of 29.5 million yuan, a dramatic decline of 1430.74% [3][5] - This marks the first time in five years that the company has reported a net loss in the first three quarters [3] Group 3: Financial Factors - The significant decline in net profit is attributed to changes in product sales structure, increased depreciation and amortization expenses, and rising management costs due to employee compensation and increased interest expenses from expanded bank loans [5] Group 4: Market Reaction - On December 24, 2025, the company's stock price surged, increasing by over 13% at one point, and closing up 8.32% at 41.51 yuan per share, with a total market capitalization of 4.184 billion yuan [6]

Summary of the Conference Call Company Overview - **Company**: 福瑞达 (Furida) - **Industry**: Cosmetics and Probiotics Key Points 1. Product Adjustments and Market Strategy - The **爱尔博士 (Aier Doctor)** probiotic series will suspend shipments by the end of 2024 due to market pricing issues, with a transition to the higher-margin **287 series** expected to complete by early 2026, alongside the launch of a new product, **王江酸 (Royal Jelly Acid)**, anticipated to drive growth in 2026. This strategy aims to protect brand integrity despite a potential short-term revenue decline of 5-10% [2][3][6] - The **颐莲 (Yilian)** brand is projected to grow rapidly in 2025, benefiting from the upgrade from **1.0 to 2.0 spray** products and effective endorsements, with expectations of double-digit growth for the year [2][5] 2. Channel Management and Inventory Control - The company has effectively addressed market pricing issues, with data indicating that the chaotic pricing phenomenon has been largely eliminated. This was achieved through a comprehensive channel management strategy, including the suspension of shipments to restore pricing integrity [2][6][7] - The company plans to increase the number of offline stores to enhance brand presence and scale, responding to the decline in online traffic benefits [8][9] 3. Product Performance and Future Expectations - The **287 series** has performed well, maintaining user retention despite price increases, and is expected to fill gaps left by declining other products [13] - The **王江酸** product, currently limited in promotion due to budget constraints, has received positive feedback and is expected to see significant growth with increased investment in 2026 [11][20] 4. Marketing and Sales Strategy - The company plans to collaborate with mid-tier influencers instead of top-tier ones, as the latter have shown declining efficiency. This shift is expected to enhance the effectiveness of marketing efforts [12] - The **颐莲** brand's marketing strategy includes a focus on high-margin non-spray products, aiming to reduce the spray product's share from 70-80% to around 65% by 2026 [15] 5. Financial Projections - The overall growth rate for **颐莲** is expected to be between 15-20% for 2025, despite a decline during the Double Eleven shopping festival being within expectations [14] - The company anticipates maintaining a gross margin of 80-85% for new products and aims to reduce costs through in-house production of raw materials and efficient packaging strategies [27] 6. Research and Development Focus - The company is prioritizing **王江酸** due to its high research barriers and broad application potential in skincare, health supplements, and medical aesthetics. This product is seen as a significant opportunity for future growth [20][21] 7. Challenges and Opportunities - The company acknowledges the challenges posed by regulatory scrutiny in the health supplement sector but is actively working to enhance its capabilities in this area, aiming to capitalize on the growing market [23][24] - The company is also exploring acquisition opportunities in the medical aesthetics and related pharmaceutical sectors, focusing on familiar fields to ensure successful integration and growth [26] 8. Internal Structure and Market Adaptation - Improvements have been made in aligning R&D with market needs, ensuring that product decisions are made collaboratively between teams to enhance market responsiveness [19] This summary encapsulates the key insights and strategic directions discussed during the conference call, highlighting the company's proactive measures in addressing market challenges and its optimistic outlook for future growth.

Group 1 - The establishment of Mao Ge Ping (Hangzhou) Cosmetics Trading Co., Ltd. has been reported, with a registered capital of 150 million yuan [1] - The company's business scope includes retail of cosmetics, sales of personal hygiene products, internet sales, and marketing planning [1] - Mao Ge Ping (01318.HK) holds 100% ownership of the newly established company [1]

Group 1 - The cosmetics sector increased by 0.73% on December 24, with Jiaheng Jiahua leading the gains [1] - The Shanghai Composite Index closed at 3940.95, up 0.53%, while the Shenzhen Component Index closed at 13486.42, up 0.88% [1] - Jiaheng Jiahua's stock price rose by 8.32% to 41.51, with a trading volume of 79,300 shares [1] Group 2 - The cosmetics sector experienced a net outflow of 52.33 million yuan from main funds, while retail investors saw a net inflow of 47.42 million yuan [2] - The trading data indicates that Qing Song Co. had a main fund net inflow of 8.18 million yuan, while Shanghai Jahwa experienced a net outflow of 3.74 million yuan [3] - The overall market sentiment showed a mixed response, with some stocks like Qing Song Co. and Jiaheng Jiahua performing positively, while others faced outflows [3]

从圣索菲亚（002572）教堂，到穿行城市的公交专线，2025年冬天不少来到哈尔滨的游客发现，这座城市多了一抹熟悉的"薇诺娜红"。 12月19日至12月21日，薇诺娜联合天猫聚划算欢聚日打造的「薇诺娜特护不红街区」在哈尔滨地标之一的圣索菲亚教堂前限时开放，成功将新品上市与"冰 雪热"深度绑定，打造了一场引发广泛共鸣的热点事件。 一、到冰雪里试一试：薇诺娜把护肤体验场搬进哈尔滨户外 冬季哈尔滨的低温、干燥、强风、室内外温差，本身正是干敏肌泛红、刺痛、起皮等问题的高发诱因。 对主打干敏修护的第二代薇诺娜特护滋润霜而言，「薇诺娜特护不红街区」的选址无疑是最具说服力的验证场。 快闪活动中，消费者可以在户外环境中直接试用产品，感知其在严寒环境下的滋润与舒缓表现。 同时，薇诺娜还结合在地特色与品牌元素，为体验者准备了青刺果奶茶、奶皮子糖葫芦等暖冬小惊喜，通过轻互动、好拍照的方式，让护肤体验自然融入冰 城的冬日生活。 配合新品上市，本月在哈尔滨冰雪季人流密集的黄金公交线路上，「薇诺娜特护滋润霜修护专列」持续运行。通过公共交通这一覆盖广泛、高渗透性媒介， 薇诺娜成功进入游客与本地居民日常视野，也将"我的脸都不红了"与第二代特 ...